Summary. We report a case of congenital dyserythropoietic anaemia, type I, with severe pre-and postnatal manifestations. Exchange transfusions were required for fetal anaemia (3´5 g/dl) at 28 and 30 weeks of gestation. Transfusions were administered at birth (Caesarean section at week 35) and at regular intervals thereafter. At 14 months, a-interferon therapy was initiated (10 6 units three times a week). This resulted in stabilization of the haemoglobin at or above 11 g/dl and a reduction in the percentage of erythroblasts with ultrastructurally abnormal heterochromatin. After 9 months, the dose of a-interferon was decreased to 10 6 units twice a week. No relapse of anaemia was noted during an additional 4 months of follow-up.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.